Details for New Drug Application (NDA): 204920
✉ Email this page to a colleague
The generic ingredient in NAPROXEN AND ESOMEPRAZOLE MAGNESIUM is esomeprazole magnesium; naproxen. There are seventy-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the esomeprazole magnesium; naproxen profile page.
Summary for 204920
Tradename: | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM |
Applicant: | Mylan |
Ingredient: | esomeprazole magnesium; naproxen |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 20MG BASE;375MG | ||||
Approval Date: | Jul 20, 2021 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 20MG BASE;500MG | ||||
Approval Date: | Jul 20, 2021 | TE: | RLD: | No |
Complete Access Available with Subscription